Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2018

View Archived Issues

CARD-carrying AML killer

Cytokine gene therapy improves spinal cord regeneration

Metabolic differences of ApoE variants

APTO-253 is able to induce DNA damage in AML cells and can exploit BRCA1/2 recombination deficiency

Kelch-like family member 7: role in breast cancer progression and utility as prognostic marker

Rare, common genetic variants contribute to preterm birth

Landos Biopharma initiates phase I study of BT-11

CytoDyn to evaluate PRO-140 in cancer and immunological indications

ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing

Novel zebrafish models of Cantu syndrome using CrispR/Cas9-based nucleotide editing

Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging

FDA lifts clinical hold on phase I/II combination study of axalimogene filolisbac plus durvalumab

Janssen patents OGA inhibitors

Idenix and Merck & Co. disclose anti-HIV-1 compounds

OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors

University of Nebraska identifies NF-kappaB activation inhibitors

GlaxoSmithKline presents NRF2 activators

Atossa Genetics initiates phase II study of endoxifen in neoadjuvant breast cancer

FDA approves first drug to treat smallpox

Researchers find a relationship between prediabetes and overactive bladder

FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

BGI-Shenzhen synthesizes new cancer vaccines

First-in-human study explores use of BAY-2287411 in mesothelin-expressing tumors

Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome

MaxCyte's cleared to begin clinical study of CAR therapy MCY-M11

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...